摘要
在筛选微生物来源的胆固醇生物合成酶抑制剂过程中,应用硅胶柱层析、LH20凝胶柱层析和重结晶等方法,从镰孢属真菌SIPI-8926菌株中。分离出具有生理活性的化合物SIPI-8926-Ⅱ。通过对其理化特性、UV、IR、MS、NMR( ̄1H和 ̄(13)C)等光谱的分析,确定其结构为:7-羟基-3-(4-羟苯基)-4H-1-苯并吡喃-4-酮,与文献报道的大豆黄酮(daidzein)结构一致。
In the course of screening for inhibitors of cholesterol biosynthetic enzyme from microbial metabolites, a physiologically active compound-SIPI-8926-Ⅱ was isolated from Fusarium fungi SIPI-8926 by solvent extraction, Silica Gel and LH20 column chromatography etc.The structure of the active compound[7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one] was elucidated to be identical with that of daidzein by means of physico-chemical properties,UV,IR,NMR(1H and ̄(13)C) spectra.
出处
《中国抗生素杂志》
CSCD
北大核心
1996年第3期173-179,共7页
Chinese Journal of Antibiotics